Table of Content

1 Gefitinib Tablets Market Overview
1.1 Gefitinib Tablets Product Overview
1.2 Gefitinib Tablets Market Segment by Type
1.2.1 Original Drugs
1.2.2 Generic Drugs
1.3 Global Gefitinib Tablets Market Size by Type
1.3.1 Global Gefitinib Tablets Market Size Overview by Type (2018-2034)
1.3.2 Global Gefitinib Tablets Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gefitinib Tablets Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gefitinib Tablets Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gefitinib Tablets Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gefitinib Tablets Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gefitinib Tablets Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gefitinib Tablets Sales Breakdown by Type (2018-2024)
2 Global Gefitinib Tablets Market Competition by Company
2.1 Global Top Players by Gefitinib Tablets Sales (2018-2024)
2.2 Global Top Players by Gefitinib Tablets Revenue (2018-2024)
2.3 Global Top Players by Gefitinib Tablets Price (2018-2024)
2.4 Global Top Manufacturers Gefitinib Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gefitinib Tablets Market Competitive Situation and Trends
2.5.1 Gefitinib Tablets Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gefitinib Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gefitinib Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Gefitinib Tablets Market
2.8 Key Manufacturers Gefitinib Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gefitinib Tablets Status and Outlook by Region
3.1 Global Gefitinib Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Gefitinib Tablets Historic Market Size by Region
3.2.1 Global Gefitinib Tablets Sales in Volume by Region (2018-2024)
3.2.2 Global Gefitinib Tablets Sales in Value by Region (2018-2024)
3.2.3 Global Gefitinib Tablets Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gefitinib Tablets Forecasted Market Size by Region
3.3.1 Global Gefitinib Tablets Sales in Volume by Region (2024-2034)
3.3.2 Global Gefitinib Tablets Sales in Value by Region (2024-2034)
3.3.3 Global Gefitinib Tablets Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Gefitinib Tablets by Application
4.1 Gefitinib Tablets Market Segment by Application
4.1.1 Breast Cancer
4.1.2 Lung Cancer
4.1.3 Other
4.2 Global Gefitinib Tablets Market Size by Application
4.2.1 Global Gefitinib Tablets Market Size Overview by Application (2018-2034)
4.2.2 Global Gefitinib Tablets Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gefitinib Tablets Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gefitinib Tablets Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gefitinib Tablets Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gefitinib Tablets Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gefitinib Tablets Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gefitinib Tablets Sales Breakdown by Application (2018-2024)
5 North America Gefitinib Tablets by Country
5.1 North America Gefitinib Tablets Historic Market Size by Country
5.1.1 North America Gefitinib Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Gefitinib Tablets Sales in Volume by Country (2018-2024)
5.1.3 North America Gefitinib Tablets Sales in Value by Country (2018-2024)
5.2 North America Gefitinib Tablets Forecasted Market Size by Country
5.2.1 North America Gefitinib Tablets Sales in Volume by Country (2024-2034)
5.2.2 North America Gefitinib Tablets Sales in Value by Country (2024-2034)
6 Europe Gefitinib Tablets by Country
6.1 Europe Gefitinib Tablets Historic Market Size by Country
6.1.1 Europe Gefitinib Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Gefitinib Tablets Sales in Volume by Country (2018-2024)
6.1.3 Europe Gefitinib Tablets Sales in Value by Country (2018-2024)
6.2 Europe Gefitinib Tablets Forecasted Market Size by Country
6.2.1 Europe Gefitinib Tablets Sales in Volume by Country (2024-2034)
6.2.2 Europe Gefitinib Tablets Sales in Value by Country (2024-2034)
7 Asia-Pacific Gefitinib Tablets by Region
7.1 Asia-Pacific Gefitinib Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Gefitinib Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Gefitinib Tablets Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gefitinib Tablets Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gefitinib Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Gefitinib Tablets Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Gefitinib Tablets Sales in Value by Region (2024-2034)
8 Latin America Gefitinib Tablets by Country
8.1 Latin America Gefitinib Tablets Historic Market Size by Country
8.1.1 Latin America Gefitinib Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Gefitinib Tablets Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gefitinib Tablets Sales in Value by Country (2018-2024)
8.2 Latin America Gefitinib Tablets Forecasted Market Size by Country
8.2.1 Latin America Gefitinib Tablets Sales in Volume by Country (2024-2034)
8.2.2 Latin America Gefitinib Tablets Sales in Value by Country (2024-2034)
9 Middle East and Africa Gefitinib Tablets by Country
9.1 Middle East and Africa Gefitinib Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Gefitinib Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Gefitinib Tablets Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gefitinib Tablets Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gefitinib Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Gefitinib Tablets Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Gefitinib Tablets Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Qilu Pharmaceutical
10.1.1 Qilu Pharmaceutical Company Information
10.1.2 Qilu Pharmaceutical Introduction and Business Overview
10.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Qilu Pharmaceutical Gefitinib Tablets Products Offered
10.1.5 Qilu Pharmaceutical Recent Development
10.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
10.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
10.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Introduction and Business Overview
10.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Products Offered
10.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Development
10.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
10.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
10.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
10.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Products Offered
10.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
10.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
10.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
10.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Introduction and Business Overview
10.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Products Offered
10.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Development
10.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
10.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
10.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
10.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Products Offered
10.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
10.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
10.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
10.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Introduction and Business Overview
10.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Products Offered
10.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Development
10.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
10.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
10.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Introduction and Business Overview
10.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Products Offered
10.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Development
10.8 NatcoPharma
10.8.1 NatcoPharma Company Information
10.8.2 NatcoPharma Introduction and Business Overview
10.8.3 NatcoPharma Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.8.4 NatcoPharma Gefitinib Tablets Products Offered
10.8.5 NatcoPharma Recent Development
10.9 AstraZeneca plc
10.9.1 AstraZeneca plc Company Information
10.9.2 AstraZeneca plc Introduction and Business Overview
10.9.3 AstraZeneca plc Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.9.4 AstraZeneca plc Gefitinib Tablets Products Offered
10.9.5 AstraZeneca plc Recent Development
10.10 Intelicure Lifesciences
10.10.1 Intelicure Lifesciences Company Information
10.10.2 Intelicure Lifesciences Introduction and Business Overview
10.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Intelicure Lifesciences Gefitinib Tablets Products Offered
10.10.5 Intelicure Lifesciences Recent Development
10.11 Weefsel Pharma
10.11.1 Weefsel Pharma Company Information
10.11.2 Weefsel Pharma Introduction and Business Overview
10.11.3 Weefsel Pharma Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Weefsel Pharma Gefitinib Tablets Products Offered
10.11.5 Weefsel Pharma Recent Development
10.12 Taj Pharmaceuticals
10.12.1 Taj Pharmaceuticals Company Information
10.12.2 Taj Pharmaceuticals Introduction and Business Overview
10.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Taj Pharmaceuticals Gefitinib Tablets Products Offered
10.12.5 Taj Pharmaceuticals Recent Development
10.13 Saintroy Lifescience
10.13.1 Saintroy Lifescience Company Information
10.13.2 Saintroy Lifescience Introduction and Business Overview
10.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Saintroy Lifescience Gefitinib Tablets Products Offered
10.13.5 Saintroy Lifescience Recent Development
10.14 Actiza Pharmaceutical
10.14.1 Actiza Pharmaceutical Company Information
10.14.2 Actiza Pharmaceutical Introduction and Business Overview
10.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Actiza Pharmaceutical Gefitinib Tablets Products Offered
10.14.5 Actiza Pharmaceutical Recent Development
10.15 Teva
10.15.1 Teva Company Information
10.15.2 Teva Introduction and Business Overview
10.15.3 Teva Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Teva Gefitinib Tablets Products Offered
10.15.5 Teva Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gefitinib Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gefitinib Tablets Industrial Chain Analysis
11.4 Gefitinib Tablets Market Dynamics
11.4.1 Gefitinib Tablets Industry Trends
11.4.2 Gefitinib Tablets Market Drivers
11.4.3 Gefitinib Tablets Market Challenges
11.4.4 Gefitinib Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gefitinib Tablets Distributors
12.3 Gefitinib Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Original Drugs
Table 2. Major Company of Generic Drugs
Table 3. Global Gefitinib Tablets Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Gefitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 5. Global Gefitinib Tablets Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Gefitinib Tablets Sales by Type (2018-2024) & (US& Million)
Table 7. Global Gefitinib Tablets Market Share in Value by Type (2018-2024)
Table 8. Global Gefitinib Tablets Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 10. Global Gefitinib Tablets Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Gefitinib Tablets Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Gefitinib Tablets Sales Market Share in Value by Type (2024-2034)
Table 13. Global Gefitinib Tablets Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Gefitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 15. North America Gefitinib Tablets Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Gefitinib Tablets Sales (K Units) by Type (2018-2024)
Table 17. Europe Gefitinib Tablets Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Gefitinib Tablets Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Gefitinib Tablets Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Gefitinib Tablets Sales (K Units) by Type (2018-2024)
Table 21. Latin America Gefitinib Tablets Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Gefitinib Tablets Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Gefitinib Tablets Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Gefitinib Tablets Sales by Company (2018-2024) & (K Units)
Table 25. Global Gefitinib Tablets Sales Share by Company (2018-2024)
Table 26. Global Gefitinib Tablets Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Gefitinib Tablets Revenue Share by Company (2018-2024)
Table 28. Global Market Gefitinib Tablets Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Gefitinib Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Gefitinib Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gefitinib Tablets as of 2022)
Table 32. Date of Key Manufacturers Enter into Gefitinib Tablets Market
Table 33. Key Manufacturers Gefitinib Tablets Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Gefitinib Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Gefitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 37. Global Gefitinib Tablets Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Gefitinib Tablets Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Gefitinib Tablets Sales Market Share in Value by Region (2018-2024)
Table 40. Global Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 42. Global Gefitinib Tablets Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Gefitinib Tablets Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Gefitinib Tablets Sales Market Share in Value by Region (2024-2034)
Table 45. Global Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Gefitinib Tablets Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Gefitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 48. Global Gefitinib Tablets Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Gefitinib Tablets Sales Market Share in Value by Application (2018-2024)
Table 51. Global Gefitinib Tablets Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 53. Global Gefitinib Tablets Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Gefitinib Tablets Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Gefitinib Tablets Sales Market Share in Value by Application (2024-2034)
Table 56. Global Gefitinib Tablets Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Gefitinib Tablets Sales by Application (2018-2024) (K Units)
Table 58. North America Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Gefitinib Tablets Sales by Application (2018-2024) (K Units)
Table 60. Europe Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Gefitinib Tablets Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Gefitinib Tablets Sales by Application (2018-2024) (K Units)
Table 64. Latin America Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Gefitinib Tablets Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Gefitinib Tablets Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 68. North America Gefitinib Tablets Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Gefitinib Tablets Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Gefitinib Tablets Sales Market Share in Value by Country (2018-2024)
Table 71. North America Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 72. North America Gefitinib Tablets Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Gefitinib Tablets Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Gefitinib Tablets Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 76. Europe Gefitinib Tablets Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Gefitinib Tablets Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Gefitinib Tablets Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 80. Europe Gefitinib Tablets Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Gefitinib Tablets Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Gefitinib Tablets Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Gefitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Gefitinib Tablets Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Gefitinib Tablets Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Gefitinib Tablets Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Gefitinib Tablets Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Gefitinib Tablets Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Gefitinib Tablets Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Gefitinib Tablets Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Gefitinib Tablets Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Gefitinib Tablets Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Gefitinib Tablets Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Gefitinib Tablets Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Gefitinib Tablets Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Gefitinib Tablets Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Gefitinib Tablets Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Gefitinib Tablets Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Gefitinib Tablets Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Gefitinib Tablets Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Gefitinib Tablets Sales Market Share in Value by Country (2024-2034)
Table 107. Qilu Pharmaceutical Company Information
Table 108. Qilu Pharmaceutical Introduction and Business Overview
Table 109. Qilu Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Qilu Pharmaceutical Gefitinib Tablets Product
Table 111. Qilu Pharmaceutical Recent Development
Table 112. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
Table 113. Sichuan Kelun Pharmaceutical Co.,Ltd. Introduction and Business Overview
Table 114. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product
Table 116. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Development
Table 117. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 118. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
Table 119. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product
Table 121. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
Table 122. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
Table 123. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 124. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 126. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Development
Table 127. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 128. Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
Table 129. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product
Table 131. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
Table 132. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 133. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 134. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 136. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Development
Table 137. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
Table 138. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Introduction and Business Overview
Table 139. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product
Table 141. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Development
Table 142. NatcoPharma Company Information
Table 143. NatcoPharma Introduction and Business Overview
Table 144. NatcoPharma Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. NatcoPharma Gefitinib Tablets Product
Table 146. NatcoPharma Recent Development
Table 147. AstraZeneca plc Company Information
Table 148. AstraZeneca plc Introduction and Business Overview
Table 149. AstraZeneca plc Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. AstraZeneca plc Gefitinib Tablets Product
Table 151. AstraZeneca plc Recent Development
Table 152. Intelicure Lifesciences Company Information
Table 153. Intelicure Lifesciences Introduction and Business Overview
Table 154. Intelicure Lifesciences Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Intelicure Lifesciences Gefitinib Tablets Product
Table 156. Intelicure Lifesciences Recent Development
Table 157. Weefsel Pharma Company Information
Table 158. Weefsel Pharma Introduction and Business Overview
Table 159. Weefsel Pharma Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Weefsel Pharma Gefitinib Tablets Product
Table 161. Weefsel Pharma Recent Development
Table 162. Taj Pharmaceuticals Company Information
Table 163. Taj Pharmaceuticals Introduction and Business Overview
Table 164. Taj Pharmaceuticals Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Taj Pharmaceuticals Gefitinib Tablets Product
Table 166. Taj Pharmaceuticals Recent Development
Table 167. Saintroy Lifescience Company Information
Table 168. Saintroy Lifescience Introduction and Business Overview
Table 169. Saintroy Lifescience Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Saintroy Lifescience Gefitinib Tablets Product
Table 171. Saintroy Lifescience Recent Development
Table 172. Actiza Pharmaceutical Company Information
Table 173. Actiza Pharmaceutical Introduction and Business Overview
Table 174. Actiza Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Actiza Pharmaceutical Gefitinib Tablets Product
Table 176. Actiza Pharmaceutical Recent Development
Table 177. Teva Company Information
Table 178. Teva Introduction and Business Overview
Table 179. Teva Gefitinib Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Teva Gefitinib Tablets Product
Table 181. Teva Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Gefitinib Tablets Market Trends
Table 185. Gefitinib Tablets Market Drivers
Table 186. Gefitinib Tablets Market Challenges
Table 187. Gefitinib Tablets Market Restraints
Table 188. Gefitinib Tablets Distributors List
Table 189. Gefitinib Tablets Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Gefitinib Tablets Product Picture
Figure 2. Global Gefitinib Tablets Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gefitinib Tablets Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Gefitinib Tablets Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Original Drugs
Figure 6. Global Original Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Generic Drugs
Figure 8. Global Generic Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Gefitinib Tablets Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Gefitinib Tablets Sales Market Share by Type in 2022 & 2034
Figure 11. North America Gefitinib Tablets Sales Market Share in Volume by Type in 2022
Figure 12. North America Gefitinib Tablets Sales Market Share in Value by Type in 2022
Figure 13. Europe Gefitinib Tablets Sales Market Share in Volume by Type in 2022
Figure 14. Europe Gefitinib Tablets Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Gefitinib Tablets Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Gefitinib Tablets Sales Market Share in Value by Type in 2022
Figure 17. Latin America Gefitinib Tablets Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Gefitinib Tablets Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Gefitinib Tablets Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Gefitinib Tablets Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Gefitinib Tablets Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Gefitinib Tablets Revenue in 2022
Figure 23. Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Breast Cancer
Figure 25. Global Breast Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Lung Cancer
Figure 27. Global Lung Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Gefitinib Tablets Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Gefitinib Tablets Sales Market Share by Application in 2022 & 2034
Figure 32. North America Gefitinib Tablets Sales Market Share in Volume by Application in 2022
Figure 33. North America Gefitinib Tablets Sales Market Share in Value by Application in 2022
Figure 34. Europe Gefitinib Tablets Sales Market Share in Volume by Application in 2022
Figure 35. Europe Gefitinib Tablets Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Gefitinib Tablets Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Gefitinib Tablets Sales Market Share in Value by Application in 2022
Figure 38. Latin America Gefitinib Tablets Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Gefitinib Tablets Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Gefitinib Tablets Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Gefitinib Tablets Manufacturing Cost Structure
Figure 43. Gefitinib Tablets Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed